Onset of secondary progressive phase and long-term evolution of multiple sclerosis (Q57912193)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Onset of secondary progressive phase and long-term evolution of multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

George C. Ebers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Antonio Scalfari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Anneke Neuhaus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Martin Daumer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

English

0 references

publication date

13 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurology, Neurosurgery and Psychiatry

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

67-75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

What is the risk of permanent disability from a multiple sclerosis relapse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Evidence for a two-stage disability progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Natural history of multiple sclerosis: a unifying concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Age and disability accumulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Progression in multiple sclerosis: further evidence of an age dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Impact of multiple sclerosis relapses on progression diminishes with time

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Natural history of multiple sclerosis in a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Reducing the probability of false positive research findings by pre-publication validation - experience with a large multiple sclerosis database

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Age at disability milestones in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Axonal loss in normal-appearing white matter in a patient with acute MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Immunopathology of secondary-progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

The contribution of demyelination to axonal loss in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Early Relapses, Onset of Progression, and Late Outcome in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

The spectrum of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

MRI as an outcome in multiple sclerosis clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

The natural history of secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

Natural history of secondary-progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304333

21 January 2018

Identifiers

DOI

10.1136/JNNP-2012-304333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23486991%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference